Promisia Integrative Limited (PIL)

[mr optimistic]

Lesh go. Might as well sell all the assets for 71.8 million and make a 400% capital gain!

[mr optimistic]

Or is there some debt?

[kiwikeith]

For What it's Worth. . . go you good thing you. . . who knows. . . maybe someone'll put in a BUY offer?

Market Announcement
30 May 2023
PROMISIA FY23 RESULTS

Year of investment as growth strategy progressed.
FY23 Results Snapshot:

• Revenue up 20% year on year, to $23.8 million.
• EBITDAF1 of $3.5 million.
• Underlying EBITDAF2 of $4.0 million, up 13% year on year.
• Net profit after tax of $0.6 million.
• Comprehensive income of $1.3 million.
• Total assets of $71.8 million.
• Good progress on growth initiatives including the Ranfurly Manor development, acquisition of Aldwins
House land and buildings and investment into systems and people.
• Well positioned to deliver increased earnings and growth in FY24.

At one tenth of a cent per share the market cap is $21m. Hard to buy it as not an obvious bargain and could get stuck with an unmarketable share. I am put off as their main asset (Ranfurly) is in Feilding which they misspell as Fielding in their NZX announcement.

[mr optimistic]

Damn. Mr Lola. It would appear the YE 31 March Accounts are absolute best case scenario, but still not a single share traded. These guys might as well de list. Whats the point. At least the EBITDA would improve by 300K per annum!

[Sideshow Bob]

Another one making a loss.....

https://www.nzx.com/announcements/422506

Promisia Healthcare Limited (NZX: PHL, “Promisia”) has announced its unaudited results for the six months ended 30 September 2023 (1H24).
The company continues to focus on its commercial objectives, delivering increasing occupancy, strong new villa sales and resales, and a relentless focus on high quality, personalised care.
Chair of Promisia, Rhonda Sherriff, commented: “Good progress is being made and Promisia is well positioned to take advantage of market opportunities. Our business is in good shape, with a strong and experienced Board and management team, and we are looking forward to delivering another year of increased earnings and business growth in FY24.”
Six month strategic and financial snapshot:
• Welcomed new Board leadership with appointment of industry expert, Rhonda Sherriff, as Chair, as well as Jill Hatchwell as Independent Director and Chair of the Audit and Risk
Management Committee.
• Restructured and strengthened the leadership team with appointment of Karen Lake as Group GM, along with a new GM of Finance and new Clinical and Quality Manager
• Review of strategy and re-set of objectives to drive commercial growth
• Continuing improvement in occupancy across the Group
• Continue to explore expansion and growth opportunities
• Revenue $12.9m, +11% yoy
• EBITDAF1 $1.6m, -11% yoy
• Net Loss After Tax $(152)k, down from a profit of $382k in prior year, reflecting one-off costs associated with the leadership and Board transition
• Total assets $73.6m, +12% yoy
• Borrowings $30.4m, +2% yoy
For further information on Promisia’s six month performance, please read the Interim Report for the six months ended 30 September 2023.
ENDS

[GTM 3442]

Oh well, easy come, easy go. . . . . next year beckons. . . . maybe one day. . . . over the rainbow. . . but how come it cost about half a million bucks for ". . . one-off costs associated with the leadership and Board transition"